Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 July 2021 | Story André Damons | Photo Supplied
Mutshidzi Abigail Mulondo, Lecturer and PhD candidate in the Faculty of Health Sciences at the University of the Free State (UFS), has been recognised as one of the Mail & Guardian’s 200 Young South Africans.

For Mutshidzi Abigail Mulondo, Lecturer and PhD candidate in the Faculty of Health Sciences at the University of the Free State (UFS), being recognised as one of the Mail & Guardian 200 Young South Africans is encapsulated in Mark Twain’s quote, “The two most important days in your life are the day you are born and the day you find out why”.

Knowing that she is living her ‘why I was born’ and actually being recognised for it, is a wonderful feeling, says Mulondo, whose passion is public health.

“I feel honoured to have been considered and counted among influential young South Africans who are doing incredible work. I am thankful to Mail & Guardian for this wonderful recognition,” says Mulondo.

Passion and commitment to promoting health 

She was nominated by one of her mentors but was sceptical that she would be in the final 200 list, as there are usually more than 5 000 applications each year. According to Mulondo, she is happy to have been proven wrong and even more grateful to be surrounded by powerful women who continue to propel her towards her purpose.

Mulondo says she always knew that she wanted to be in a position to help alleviate pain and suffering and that health would be her avenue to serve humanity. Says Mulondo: “When I started with an interdisciplinary PhD in Health Professions Education and Community Health, it further solidified my passion and commitment to promoting health.”
“I am equally passionate about mental health wellness. After completing a master’s degree in Psychology at the University of Pretoria, I knew it would provide me with an opportunity to impact people’s lives more holistically. An opportunity to not only promote physical health, but to also advocate for mental health.”

Hope for the youth of South Africa

Mulondo’s message to young people is also the motto she lives by: “Be kinder to yourself”. So many times, we are hard on ourselves when we fail or when we do not accomplish what we set out to accomplish at a particular time. 

“Please remember that you are the only you that will ever be. You must therefore be gentler with yourself; despite what you thought you would have achieved thus far, appreciate how far you have actually come against whatever odds,” says Mulondo.

Her hope for the youth of South Africa is that we reach a point where fighting against issues such as gender-based violence (GBV), systematic racism, gender inequality, high unemployment rates, and all other constructs that affect our youth and country is a matter of the past. “While we envision that day, I hope that we all continue to stand together and speak up for the vulnerable, marginalised, and disenfranchised. I am confident that we will see and experience the fullest potential of our youth, in this lifetime (Jeremiah 29:11).”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept